Global Celecoxib Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Celecoxib market size is predicted to grow from US$ 1460 million in 2025 to US$ 2410 million in 2031; it is expected to grow at a CAGR of 8.7% from 2025 to 2031.
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
LP Information, Inc. (LPI) ' newest research report, the “Celecoxib Industry Forecast” looks at past sales and reviews total world Celecoxib sales in 2024, providing a comprehensive analysis by region and market sector of projected Celecoxib sales for 2025 through 2031. With Celecoxib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Celecoxib industry.
This Insight Report provides a comprehensive analysis of the global Celecoxib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Celecoxib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Celecoxib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Celecoxib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Celecoxib.
This report presents a comprehensive overview, market shares, and growth opportunities of Celecoxib market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Celecoxib market?
What factors are driving Celecoxib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Celecoxib market opportunities vary by end market size?
How does Celecoxib break out by Type, by Application?
The global Celecoxib market size is predicted to grow from US$ 1460 million in 2025 to US$ 2410 million in 2031; it is expected to grow at a CAGR of 8.7% from 2025 to 2031.
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
LP Information, Inc. (LPI) ' newest research report, the “Celecoxib Industry Forecast” looks at past sales and reviews total world Celecoxib sales in 2024, providing a comprehensive analysis by region and market sector of projected Celecoxib sales for 2025 through 2031. With Celecoxib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Celecoxib industry.
This Insight Report provides a comprehensive analysis of the global Celecoxib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Celecoxib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Celecoxib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Celecoxib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Celecoxib.
This report presents a comprehensive overview, market shares, and growth opportunities of Celecoxib market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 50mg
- 100mg
- 200mg
- 400mg
- Rheumatoid arthritis
- osteoarthritis
- Acute pain
- Musculoskeletal pain
- Other diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc
- Teva
- Mylan
- Apotex
- Lupin
- Hengrui Medicine
What is the 10-year outlook for the global Celecoxib market?
What factors are driving Celecoxib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Celecoxib market opportunities vary by end market size?
How does Celecoxib break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Celecoxib Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Celecoxib by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Celecoxib by Country/Region, 2020, 2024 & 2031
2.2 Celecoxib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.2.3 200mg
2.2.4 400mg
2.3 Celecoxib Sales by Type
2.3.1 Global Celecoxib Sales Market Share by Type (2020-2025)
2.3.2 Global Celecoxib Revenue and Market Share by Type (2020-2025)
2.3.3 Global Celecoxib Sale Price by Type (2020-2025)
2.4 Celecoxib Segment by Application
2.4.1 Rheumatoid arthritis
2.4.2 osteoarthritis
2.4.3 Acute pain
2.4.4 Musculoskeletal pain
2.4.5 Other diseases
2.5 Celecoxib Sales by Application
2.5.1 Global Celecoxib Sale Market Share by Application (2020-2025)
2.5.2 Global Celecoxib Revenue and Market Share by Application (2020-2025)
2.5.3 Global Celecoxib Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Celecoxib Breakdown Data by Company
3.1.1 Global Celecoxib Annual Sales by Company (2020-2025)
3.1.2 Global Celecoxib Sales Market Share by Company (2020-2025)
3.2 Global Celecoxib Annual Revenue by Company (2020-2025)
3.2.1 Global Celecoxib Revenue by Company (2020-2025)
3.2.2 Global Celecoxib Revenue Market Share by Company (2020-2025)
3.3 Global Celecoxib Sale Price by Company
3.4 Key Manufacturers Celecoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celecoxib Product Location Distribution
3.4.2 Players Celecoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CELECOXIB BY GEOGRAPHIC REGION
4.1 World Historic Celecoxib Market Size by Geographic Region (2020-2025)
4.1.1 Global Celecoxib Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Celecoxib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Celecoxib Market Size by Country/Region (2020-2025)
4.2.1 Global Celecoxib Annual Sales by Country/Region (2020-2025)
4.2.2 Global Celecoxib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Celecoxib Sales Growth
4.4 APAC Celecoxib Sales Growth
4.5 Europe Celecoxib Sales Growth
4.6 Middle East & Africa Celecoxib Sales Growth
5 AMERICAS
5.1 Americas Celecoxib Sales by Country
5.1.1 Americas Celecoxib Sales by Country (2020-2025)
5.1.2 Americas Celecoxib Revenue by Country (2020-2025)
5.2 Americas Celecoxib Sales by Type (2020-2025)
5.3 Americas Celecoxib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celecoxib Sales by Region
6.1.1 APAC Celecoxib Sales by Region (2020-2025)
6.1.2 APAC Celecoxib Revenue by Region (2020-2025)
6.2 APAC Celecoxib Sales by Type (2020-2025)
6.3 APAC Celecoxib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Celecoxib by Country
7.1.1 Europe Celecoxib Sales by Country (2020-2025)
7.1.2 Europe Celecoxib Revenue by Country (2020-2025)
7.2 Europe Celecoxib Sales by Type (2020-2025)
7.3 Europe Celecoxib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Celecoxib by Country
8.1.1 Middle East & Africa Celecoxib Sales by Country (2020-2025)
8.1.2 Middle East & Africa Celecoxib Revenue by Country (2020-2025)
8.2 Middle East & Africa Celecoxib Sales by Type (2020-2025)
8.3 Middle East & Africa Celecoxib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Celecoxib
10.3 Manufacturing Process Analysis of Celecoxib
10.4 Industry Chain Structure of Celecoxib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Celecoxib Distributors
11.3 Celecoxib Customer
12 WORLD FORECAST REVIEW FOR CELECOXIB BY GEOGRAPHIC REGION
12.1 Global Celecoxib Market Size Forecast by Region
12.1.1 Global Celecoxib Forecast by Region (2026-2031)
12.1.2 Global Celecoxib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Celecoxib Forecast by Type (2026-2031)
12.7 Global Celecoxib Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Celecoxib Product Portfolios and Specifications
13.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Celecoxib Product Portfolios and Specifications
13.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Celecoxib Product Portfolios and Specifications
13.3.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Apotex
13.4.1 Apotex Company Information
13.4.2 Apotex Celecoxib Product Portfolios and Specifications
13.4.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Apotex Main Business Overview
13.4.5 Apotex Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin Celecoxib Product Portfolios and Specifications
13.5.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Hengrui Medicine
13.6.1 Hengrui Medicine Company Information
13.6.2 Hengrui Medicine Celecoxib Product Portfolios and Specifications
13.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hengrui Medicine Main Business Overview
13.6.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Celecoxib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Celecoxib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 100mg
Table 5. Major Players of 200mg
Table 6. Major Players of 400mg
Table 7. Global Celecoxib Sales byType (2020-2025) & (K Units)
Table 8. Global Celecoxib Sales Market Share byType (2020-2025)
Table 9. Global Celecoxib Revenue byType (2020-2025) & ($ million)
Table 10. Global Celecoxib Revenue Market Share byType (2020-2025)
Table 11. Global Celecoxib Sale Price byType (2020-2025) & (US$/Unit)
Table 12. Global Celecoxib Sale by Application (2020-2025) & (K Units)
Table 13. Global Celecoxib Sale Market Share by Application (2020-2025)
Table 14. Global Celecoxib Revenue by Application (2020-2025) & ($ million)
Table 15. Global Celecoxib Revenue Market Share by Application (2020-2025)
Table 16. Global Celecoxib Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Celecoxib Sales by Company (2020-2025) & (K Units)
Table 18. Global Celecoxib Sales Market Share by Company (2020-2025)
Table 19. Global Celecoxib Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Celecoxib Revenue Market Share by Company (2020-2025)
Table 21. Global Celecoxib Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Celecoxib Producing Area Distribution and Sales Area
Table 23. Players Celecoxib Products Offered
Table 24. Celecoxib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Celecoxib Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Celecoxib Sales Market Share Geographic Region (2020-2025)
Table 29. Global Celecoxib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Celecoxib Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Celecoxib Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Celecoxib Sales Market Share by Country/Region (2020-2025)
Table 33. Global Celecoxib Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Celecoxib Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Celecoxib Sales by Country (2020-2025) & (K Units)
Table 36. Americas Celecoxib Sales Market Share by Country (2020-2025)
Table 37. Americas Celecoxib Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Celecoxib Sales byType (2020-2025) & (K Units)
Table 39. Americas Celecoxib Sales by Application (2020-2025) & (K Units)
Table 40. APAC Celecoxib Sales by Region (2020-2025) & (K Units)
Table 41. APAC Celecoxib Sales Market Share by Region (2020-2025)
Table 42. APAC Celecoxib Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Celecoxib Sales byType (2020-2025) & (K Units)
Table 44. APAC Celecoxib Sales by Application (2020-2025) & (K Units)
Table 45. Europe Celecoxib Sales by Country (2020-2025) & (K Units)
Table 46. Europe Celecoxib Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Celecoxib Sales byType (2020-2025) & (K Units)
Table 48. Europe Celecoxib Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Celecoxib Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Celecoxib Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Celecoxib Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Celecoxib Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Celecoxib
Table 54. Key Market Challenges & Risks of Celecoxib
Table 55. Key IndustryTrends of Celecoxib
Table 56. Celecoxib Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Celecoxib Distributors List
Table 59. Celecoxib Customer List
Table 60. Global Celecoxib SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Celecoxib RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Celecoxib SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Celecoxib Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Celecoxib SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Celecoxib Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Celecoxib SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Celecoxib RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Celecoxib SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Celecoxib RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Celecoxib SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Celecoxib RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Celecoxib SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Celecoxib RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Pfizer Inc Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Inc Celecoxib Product Portfolios and Specifications
Table 76. Pfizer Inc Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. Pfizer Inc Main Business
Table 78. Pfizer Inc Latest Developments
Table 79.Teva Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 80.Teva Celecoxib Product Portfolios and Specifications
Table 81.Teva Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82.Teva Main Business
Table 83.Teva Latest Developments
Table 84. Mylan Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Celecoxib Product Portfolios and Specifications
Table 86. Mylan Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Apotex Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 90. Apotex Celecoxib Product Portfolios and Specifications
Table 91. Apotex Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Apotex Main Business
Table 93. Apotex Latest Developments
Table 94. Lupin Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 95. Lupin Celecoxib Product Portfolios and Specifications
Table 96. Lupin Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Lupin Main Business
Table 98. Lupin Latest Developments
Table 99. Hengrui Medicine Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 100. Hengrui Medicine Celecoxib Product Portfolios and Specifications
Table 101. Hengrui Medicine Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Hengrui Medicine Main Business
Table 103. Hengrui Medicine Latest Developments
LIST OFFIGURES
Figure 1. Picture of Celecoxib
Figure 2. Celecoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celecoxib Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Celecoxib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Celecoxib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Celecoxib Sales Market Share by Country/Region (2024)
Figure 10. Celecoxib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 50mg
Figure 12. Product Picture of 100mg
Figure 13. Product Picture of 200mg
Figure 14. Product Picture of 400mg
Figure 15. Global Celecoxib Sales Market Share byType in 2025
Figure 16. Global Celecoxib Revenue Market Share byType (2020-2025)
Figure 17. Celecoxib Consumed in Rheumatoid arthritis
Figure 18. Global Celecoxib Market: Rheumatoid arthritis (2020-2025) & (K Units)
Figure 19. Celecoxib Consumed in osteoarthritis
Figure 20. Global Celecoxib Market: osteoarthritis (2020-2025) & (K Units)
Figure 21. Celecoxib Consumed in Acute pain
Figure 22. Global Celecoxib Market: Acute pain (2020-2025) & (K Units)
Figure 23. Celecoxib Consumed in Musculoskeletal pain
Figure 24. Global Celecoxib Market: Musculoskeletal pain (2020-2025) & (K Units)
Figure 25. Celecoxib Consumed in Other diseases
Figure 26. Global Celecoxib Market: Other diseases (2020-2025) & (K Units)
Figure 27. Global Celecoxib Sale Market Share by Application (2024)
Figure 28. Global Celecoxib Revenue Market Share by Application in 2025
Figure 29. Celecoxib Sales by Company in 2025 (K Units)
Figure 30. Global Celecoxib Sales Market Share by Company in 2025
Figure 31. Celecoxib Revenue by Company in 2025 ($ millions)
Figure 32. Global Celecoxib Revenue Market Share by Company in 2025
Figure 33. Global Celecoxib Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Celecoxib Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Celecoxib Sales 2020-2025 (K Units)
Figure 36. Americas Celecoxib Revenue 2020-2025 ($ millions)
Figure 37. APAC Celecoxib Sales 2020-2025 (K Units)
Figure 38. APAC Celecoxib Revenue 2020-2025 ($ millions)
Figure 39. Europe Celecoxib Sales 2020-2025 (K Units)
Figure 40. Europe Celecoxib Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Celecoxib Sales 2020-2025 (K Units)
Figure 42. Middle East & Africa Celecoxib Revenue 2020-2025 ($ millions)
Figure 43. Americas Celecoxib Sales Market Share by Country in 2025
Figure 44. Americas Celecoxib Revenue Market Share by Country (2020-2025)
Figure 45. Americas Celecoxib Sales Market Share byType (2020-2025)
Figure 46. Americas Celecoxib Sales Market Share by Application (2020-2025)
Figure 47. United States Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Celecoxib Sales Market Share by Region in 2025
Figure 52. APAC Celecoxib Revenue Market Share by Region (2020-2025)
Figure 53. APAC Celecoxib Sales Market Share byType (2020-2025)
Figure 54. APAC Celecoxib Sales Market Share by Application (2020-2025)
Figure 55. China Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 59. India Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 61. ChinaTaiwan Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Celecoxib Sales Market Share by Country in 2025
Figure 63. Europe Celecoxib Revenue Market Share by Country (2020-2025)
Figure 64. Europe Celecoxib Sales Market Share byType (2020-2025)
Figure 65. Europe Celecoxib Sales Market Share by Application (2020-2025)
Figure 66. Germany Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 67.France Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Celecoxib Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Celecoxib Sales Market Share byType (2020-2025)
Figure 73. Middle East & Africa Celecoxib Sales Market Share by Application (2020-2025)
Figure 74. Egypt Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 77.Turkey Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Celecoxib in 2025
Figure 80. Manufacturing Process Analysis of Celecoxib
Figure 81. Industry Chain Structure of Celecoxib
Figure 82. Channels of Distribution
Figure 83. Global Celecoxib Sales MarketForecast by Region (2026-2031)
Figure 84. Global Celecoxib Revenue Market ShareForecast by Region (2026-2031)
Figure 85. Global Celecoxib Sales Market ShareForecast byType (2026-2031)
Figure 86. Global Celecoxib Revenue Market ShareForecast byType (2026-2031)
Figure 87. Global Celecoxib Sales Market ShareForecast by Application (2026-2031)
Figure 88. Global Celecoxib Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Celecoxib Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Celecoxib by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Celecoxib by Country/Region, 2020, 2024 & 2031
2.2 Celecoxib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.2.3 200mg
2.2.4 400mg
2.3 Celecoxib Sales by Type
2.3.1 Global Celecoxib Sales Market Share by Type (2020-2025)
2.3.2 Global Celecoxib Revenue and Market Share by Type (2020-2025)
2.3.3 Global Celecoxib Sale Price by Type (2020-2025)
2.4 Celecoxib Segment by Application
2.4.1 Rheumatoid arthritis
2.4.2 osteoarthritis
2.4.3 Acute pain
2.4.4 Musculoskeletal pain
2.4.5 Other diseases
2.5 Celecoxib Sales by Application
2.5.1 Global Celecoxib Sale Market Share by Application (2020-2025)
2.5.2 Global Celecoxib Revenue and Market Share by Application (2020-2025)
2.5.3 Global Celecoxib Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Celecoxib Breakdown Data by Company
3.1.1 Global Celecoxib Annual Sales by Company (2020-2025)
3.1.2 Global Celecoxib Sales Market Share by Company (2020-2025)
3.2 Global Celecoxib Annual Revenue by Company (2020-2025)
3.2.1 Global Celecoxib Revenue by Company (2020-2025)
3.2.2 Global Celecoxib Revenue Market Share by Company (2020-2025)
3.3 Global Celecoxib Sale Price by Company
3.4 Key Manufacturers Celecoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celecoxib Product Location Distribution
3.4.2 Players Celecoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CELECOXIB BY GEOGRAPHIC REGION
4.1 World Historic Celecoxib Market Size by Geographic Region (2020-2025)
4.1.1 Global Celecoxib Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Celecoxib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Celecoxib Market Size by Country/Region (2020-2025)
4.2.1 Global Celecoxib Annual Sales by Country/Region (2020-2025)
4.2.2 Global Celecoxib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Celecoxib Sales Growth
4.4 APAC Celecoxib Sales Growth
4.5 Europe Celecoxib Sales Growth
4.6 Middle East & Africa Celecoxib Sales Growth
5 AMERICAS
5.1 Americas Celecoxib Sales by Country
5.1.1 Americas Celecoxib Sales by Country (2020-2025)
5.1.2 Americas Celecoxib Revenue by Country (2020-2025)
5.2 Americas Celecoxib Sales by Type (2020-2025)
5.3 Americas Celecoxib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celecoxib Sales by Region
6.1.1 APAC Celecoxib Sales by Region (2020-2025)
6.1.2 APAC Celecoxib Revenue by Region (2020-2025)
6.2 APAC Celecoxib Sales by Type (2020-2025)
6.3 APAC Celecoxib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Celecoxib by Country
7.1.1 Europe Celecoxib Sales by Country (2020-2025)
7.1.2 Europe Celecoxib Revenue by Country (2020-2025)
7.2 Europe Celecoxib Sales by Type (2020-2025)
7.3 Europe Celecoxib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Celecoxib by Country
8.1.1 Middle East & Africa Celecoxib Sales by Country (2020-2025)
8.1.2 Middle East & Africa Celecoxib Revenue by Country (2020-2025)
8.2 Middle East & Africa Celecoxib Sales by Type (2020-2025)
8.3 Middle East & Africa Celecoxib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Celecoxib
10.3 Manufacturing Process Analysis of Celecoxib
10.4 Industry Chain Structure of Celecoxib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Celecoxib Distributors
11.3 Celecoxib Customer
12 WORLD FORECAST REVIEW FOR CELECOXIB BY GEOGRAPHIC REGION
12.1 Global Celecoxib Market Size Forecast by Region
12.1.1 Global Celecoxib Forecast by Region (2026-2031)
12.1.2 Global Celecoxib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Celecoxib Forecast by Type (2026-2031)
12.7 Global Celecoxib Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Celecoxib Product Portfolios and Specifications
13.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Celecoxib Product Portfolios and Specifications
13.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Celecoxib Product Portfolios and Specifications
13.3.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Apotex
13.4.1 Apotex Company Information
13.4.2 Apotex Celecoxib Product Portfolios and Specifications
13.4.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Apotex Main Business Overview
13.4.5 Apotex Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin Celecoxib Product Portfolios and Specifications
13.5.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Hengrui Medicine
13.6.1 Hengrui Medicine Company Information
13.6.2 Hengrui Medicine Celecoxib Product Portfolios and Specifications
13.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hengrui Medicine Main Business Overview
13.6.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Celecoxib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Celecoxib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 50mg
Table 4. Major Players of 100mg
Table 5. Major Players of 200mg
Table 6. Major Players of 400mg
Table 7. Global Celecoxib Sales byType (2020-2025) & (K Units)
Table 8. Global Celecoxib Sales Market Share byType (2020-2025)
Table 9. Global Celecoxib Revenue byType (2020-2025) & ($ million)
Table 10. Global Celecoxib Revenue Market Share byType (2020-2025)
Table 11. Global Celecoxib Sale Price byType (2020-2025) & (US$/Unit)
Table 12. Global Celecoxib Sale by Application (2020-2025) & (K Units)
Table 13. Global Celecoxib Sale Market Share by Application (2020-2025)
Table 14. Global Celecoxib Revenue by Application (2020-2025) & ($ million)
Table 15. Global Celecoxib Revenue Market Share by Application (2020-2025)
Table 16. Global Celecoxib Sale Price by Application (2020-2025) & (US$/Unit)
Table 17. Global Celecoxib Sales by Company (2020-2025) & (K Units)
Table 18. Global Celecoxib Sales Market Share by Company (2020-2025)
Table 19. Global Celecoxib Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Celecoxib Revenue Market Share by Company (2020-2025)
Table 21. Global Celecoxib Sale Price by Company (2020-2025) & (US$/Unit)
Table 22. Key Manufacturers Celecoxib Producing Area Distribution and Sales Area
Table 23. Players Celecoxib Products Offered
Table 24. Celecoxib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Celecoxib Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Celecoxib Sales Market Share Geographic Region (2020-2025)
Table 29. Global Celecoxib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Celecoxib Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Celecoxib Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Celecoxib Sales Market Share by Country/Region (2020-2025)
Table 33. Global Celecoxib Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Celecoxib Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Celecoxib Sales by Country (2020-2025) & (K Units)
Table 36. Americas Celecoxib Sales Market Share by Country (2020-2025)
Table 37. Americas Celecoxib Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Celecoxib Sales byType (2020-2025) & (K Units)
Table 39. Americas Celecoxib Sales by Application (2020-2025) & (K Units)
Table 40. APAC Celecoxib Sales by Region (2020-2025) & (K Units)
Table 41. APAC Celecoxib Sales Market Share by Region (2020-2025)
Table 42. APAC Celecoxib Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Celecoxib Sales byType (2020-2025) & (K Units)
Table 44. APAC Celecoxib Sales by Application (2020-2025) & (K Units)
Table 45. Europe Celecoxib Sales by Country (2020-2025) & (K Units)
Table 46. Europe Celecoxib Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Celecoxib Sales byType (2020-2025) & (K Units)
Table 48. Europe Celecoxib Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Celecoxib Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Celecoxib Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Celecoxib Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Celecoxib Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Celecoxib
Table 54. Key Market Challenges & Risks of Celecoxib
Table 55. Key IndustryTrends of Celecoxib
Table 56. Celecoxib Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Celecoxib Distributors List
Table 59. Celecoxib Customer List
Table 60. Global Celecoxib SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Celecoxib RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Celecoxib SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Celecoxib Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Celecoxib SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Celecoxib Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Celecoxib SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Celecoxib RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Celecoxib SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Celecoxib RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Celecoxib SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Celecoxib RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Celecoxib SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Celecoxib RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Pfizer Inc Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Inc Celecoxib Product Portfolios and Specifications
Table 76. Pfizer Inc Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 77. Pfizer Inc Main Business
Table 78. Pfizer Inc Latest Developments
Table 79.Teva Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 80.Teva Celecoxib Product Portfolios and Specifications
Table 81.Teva Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 82.Teva Main Business
Table 83.Teva Latest Developments
Table 84. Mylan Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Celecoxib Product Portfolios and Specifications
Table 86. Mylan Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Apotex Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 90. Apotex Celecoxib Product Portfolios and Specifications
Table 91. Apotex Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 92. Apotex Main Business
Table 93. Apotex Latest Developments
Table 94. Lupin Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 95. Lupin Celecoxib Product Portfolios and Specifications
Table 96. Lupin Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 97. Lupin Main Business
Table 98. Lupin Latest Developments
Table 99. Hengrui Medicine Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 100. Hengrui Medicine Celecoxib Product Portfolios and Specifications
Table 101. Hengrui Medicine Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 102. Hengrui Medicine Main Business
Table 103. Hengrui Medicine Latest Developments
LIST OFFIGURES
Figure 1. Picture of Celecoxib
Figure 2. Celecoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celecoxib Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Celecoxib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Celecoxib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Celecoxib Sales Market Share by Country/Region (2024)
Figure 10. Celecoxib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 50mg
Figure 12. Product Picture of 100mg
Figure 13. Product Picture of 200mg
Figure 14. Product Picture of 400mg
Figure 15. Global Celecoxib Sales Market Share byType in 2025
Figure 16. Global Celecoxib Revenue Market Share byType (2020-2025)
Figure 17. Celecoxib Consumed in Rheumatoid arthritis
Figure 18. Global Celecoxib Market: Rheumatoid arthritis (2020-2025) & (K Units)
Figure 19. Celecoxib Consumed in osteoarthritis
Figure 20. Global Celecoxib Market: osteoarthritis (2020-2025) & (K Units)
Figure 21. Celecoxib Consumed in Acute pain
Figure 22. Global Celecoxib Market: Acute pain (2020-2025) & (K Units)
Figure 23. Celecoxib Consumed in Musculoskeletal pain
Figure 24. Global Celecoxib Market: Musculoskeletal pain (2020-2025) & (K Units)
Figure 25. Celecoxib Consumed in Other diseases
Figure 26. Global Celecoxib Market: Other diseases (2020-2025) & (K Units)
Figure 27. Global Celecoxib Sale Market Share by Application (2024)
Figure 28. Global Celecoxib Revenue Market Share by Application in 2025
Figure 29. Celecoxib Sales by Company in 2025 (K Units)
Figure 30. Global Celecoxib Sales Market Share by Company in 2025
Figure 31. Celecoxib Revenue by Company in 2025 ($ millions)
Figure 32. Global Celecoxib Revenue Market Share by Company in 2025
Figure 33. Global Celecoxib Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Celecoxib Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Celecoxib Sales 2020-2025 (K Units)
Figure 36. Americas Celecoxib Revenue 2020-2025 ($ millions)
Figure 37. APAC Celecoxib Sales 2020-2025 (K Units)
Figure 38. APAC Celecoxib Revenue 2020-2025 ($ millions)
Figure 39. Europe Celecoxib Sales 2020-2025 (K Units)
Figure 40. Europe Celecoxib Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Celecoxib Sales 2020-2025 (K Units)
Figure 42. Middle East & Africa Celecoxib Revenue 2020-2025 ($ millions)
Figure 43. Americas Celecoxib Sales Market Share by Country in 2025
Figure 44. Americas Celecoxib Revenue Market Share by Country (2020-2025)
Figure 45. Americas Celecoxib Sales Market Share byType (2020-2025)
Figure 46. Americas Celecoxib Sales Market Share by Application (2020-2025)
Figure 47. United States Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Celecoxib Sales Market Share by Region in 2025
Figure 52. APAC Celecoxib Revenue Market Share by Region (2020-2025)
Figure 53. APAC Celecoxib Sales Market Share byType (2020-2025)
Figure 54. APAC Celecoxib Sales Market Share by Application (2020-2025)
Figure 55. China Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 59. India Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 61. ChinaTaiwan Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Celecoxib Sales Market Share by Country in 2025
Figure 63. Europe Celecoxib Revenue Market Share by Country (2020-2025)
Figure 64. Europe Celecoxib Sales Market Share byType (2020-2025)
Figure 65. Europe Celecoxib Sales Market Share by Application (2020-2025)
Figure 66. Germany Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 67.France Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Celecoxib Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Celecoxib Sales Market Share byType (2020-2025)
Figure 73. Middle East & Africa Celecoxib Sales Market Share by Application (2020-2025)
Figure 74. Egypt Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 77.Turkey Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Celecoxib Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Celecoxib in 2025
Figure 80. Manufacturing Process Analysis of Celecoxib
Figure 81. Industry Chain Structure of Celecoxib
Figure 82. Channels of Distribution
Figure 83. Global Celecoxib Sales MarketForecast by Region (2026-2031)
Figure 84. Global Celecoxib Revenue Market ShareForecast by Region (2026-2031)
Figure 85. Global Celecoxib Sales Market ShareForecast byType (2026-2031)
Figure 86. Global Celecoxib Revenue Market ShareForecast byType (2026-2031)
Figure 87. Global Celecoxib Sales Market ShareForecast by Application (2026-2031)
Figure 88. Global Celecoxib Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Aesthetic Lasers and Energy Devices Market Growth 2025-2031
US$ 3,660.00
January 2025
133 pages
Global First Aid Kits and Cabinets Market Growth 2023-2029
US$ 3,660.00
March 2023
117 pages
Global Mechanical Medical Ventilator Market Growth 2024-2030
US$ 3,660.00
December 2024
119 pages
